D3-binding molecules and uses thereof
US-2024376194-A1 · Nov 14, 2024 · US
US9952215B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9952215-B2 |
| Application number | US-201514629028-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 23, 2015 |
| Priority date | Aug 24, 2012 |
| Publication date | Apr 24, 2018 |
| Grant date | Apr 24, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of analyzing an exosome is provided for detecting abnormality in a cell, including: (a) a step of preparing an exosome from a sample; (b) a step of bringing the exosome prepared in the step (a) into contact with a first antibody to a protein which exists on the surface of the exosome as an antigen and forming a first antibody-exosome complex; and (c) a step of measuring a zeta potential of the first antibody-exosome complex.
Opening claim text (preview).
What is claimed is: 1. A method of analyzing an exosome, comprising: (a) preparing an exosome from a sample; (b) bringing the exosome prepared in (a) into contact with a first antibody to a protein that exists on the surface of the exosome as an antigen thereby forming a first antibody-exosome complex; (c) irradiating the first antibody-exosome complex with a laser beam to obtain a particle image of the first antibody-exosome complex using scattered light, while separating the first antibody-exosome complex from other substances through electrophoresis; (d) determining an electrophoresis mobility of the first antibody-exosome complex based on the particle image; and (e) determining a zeta potential of the first antibody-exosome complex based on the electrophoresis mobility of the first antibody-exosome complex. 2. The method of analyzing an exosome according to claim 1 , wherein the protein is highly expressed in an abnormal cell or a normal cell. 3. The method of analyzing an exosome according to claim 1 , wherein the protein is specifically expressed in an abnormal cell or in a normal cell. 4. The method of analyzing an exosome according to claim 1 , wherein the first antibody is formed of a plurality of types of antibodies. 5. A method of analyzing an exosome comprising; (a) preparing an exosome from a sample; (b) bringing the exosome prepared in (a) into contact with a first antibody to a protein that exists on the surface of the exosome as an antigen and forming a first antibody-exosome complex; (c) measuring a zeta potential of the first antibody-exosome complex (d) bringing the exosome prepared in (a) into contact with a second antibody to a protein that exists on the surface of the exosome as an antigen and forming a second antibody-exosome complex; and (e) measuring a zeta potential of the second antibody-exosome complex, after (c). 6. The method of analyzing an exosome according to claim 5 , wherein (e) comprises separating the second antibody-exosome complex from other substances through electrophoresis and measuring the zeta potential of the second antibody-exosome complex at one particle level. 7. The method of analyzing an exosome according to claim 6 , wherein (e) comprises measuring the zeta potential of the second antibody-exosome complex based on mobility which is optically measured. 8. The method of analyzing an exosome according to claim 6 , wherein (e) comprises measuring the zeta potential of the second antibody-exosome complex based on mobility which is measured by obtaining a particle image using scattered light. 9. The method of analyzing an exosome according to claim 5 , wherein the protein is highly and specifically expressed in an organ as an antigen. 10. An exosome analysis apparatus, comprising: a preparation member configured for preparing an exosome from a sample; a complex formation member configured for bringing the exosome into contact with an antibody to a protein that exists on the surface of the exosome as an antigen and thereby forming an antibody-exosome complex; an electrophoresis member configured for separating the antibody-exosome complex from other substances through electrophoresis; a laser beam source for irradiating the antibody-exosome complex; a high-sensitivity camera for obtaining a particle image of the antibody-exosome complex using scattered light to determine the electrophoresis mobility of the first antibody-exosome complex; and a zeta potential measuring member for measuring zeta potential based on the electrophoresis mobility of the first antibody-exosome complex. 11. A method of analyzing an exosome, comprising: (a) preparing an exosome from a sample; (b) bringing the exosome prepared in (a) into contact with a molecule that specifically binds to a biomolecule existing on the surface of the exosome thereby forming a complex; (c) irradiating the complex with a laser beam to obtain a particle image of the complex using scattered light, while separating the complex from other substances through electrophoresis; (d) determining an electrophoresis mobility of the complex based on the particle image; and (e) determining a zeta potential of the complex based on the electrophoresis mobility of the first antibody-exosome complex. 12. An exosome analysis apparatus, comprising: a preparation member configured for preparing an exosome from a sample; a complex formation member configured for bringing the exosome into contact with a molecule that specifically binds to a biomolecule existing on the surface of the exosome to form a complex; an electrophoresis member configured for separating the complex from other substances through electrophoresis; a laser beam source for irradiating the complex; a high-sensitivity camera for obtaining a particle image of the complex using scattered light to determine the electrophoresis mobility of the complex; and a zeta potential measuring member for measuring zeta potential based on the electrophoresis mobility of the complex.
involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title
Microapparatus (sample containers with integrated microfluidic structures B01L3/5027) · CPC title
using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds} · CPC title
Nanoparticles · CPC title
Immunoelectrophoresis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.